Document Detail

Yttrium-based therapy for neuroendocrine tumors.
MedLine Citation:
PMID:  25029936     Owner:  NLM     Status:  In-Data-Review    
Peptide receptor radionuclide therapy with (90)Y-peptides is generally well tolerated. Acute side effects are usually mild; some are related to the coadministration of amino acids and others to the radiopeptide itself. Chronic and permanent effects on target organs, particularly kidneys and bone marrow, are generally mild if necessary precautions are taken. The potential risk to kidney and red marrow limits the amount of radioactivity that may be administered. However, when tumor masses are irradiated with adequate doses, volume reduction may be observed. (90)Y-octreotide has been the most used radiopeptide in the first 8 to 10 years of experience.
Lisa Bodei; Marta Cremonesi; Giovanni Paganelli
Related Documents :
8293426 - Inhibition of rat mammary carcinogenesis by inositol hexaphosphate (phytic acid). a pil...
16166336 - Phenethyl isothiocyanate and sulforaphane and their n-acetylcysteine conjugates inhibit...
15345156 - Increased tumor growth after high pressure pneumoperitoneum with helium and air.
12229996 - Small-sample inference for incomplete longitudinal data with truncation and censoring i...
1991996 - Splenic macrophages from tumor-bearing mice co-expressing mac-1 and mac-2 antigens exer...
8290586 - Function of a human cyclin gene as an oncogene.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  PET clinics     Volume:  9     ISSN:  1556-8598     ISO Abbreviation:  PET Clin     Publication Date:  2014 Jan 
Date Detail:
Created Date:  2014-07-17     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101260152     Medline TA:  PET Clin     Country:  United States    
Other Details:
Languages:  eng     Pagination:  71-82     Citation Subset:  IM    
Copyright Information:
Copyright © 2014 Elsevier Inc. All rights reserved.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Preclinical Studies of SPECT and PET Tracers for NET.
Next Document:  Patient Selection for Personalized Peptide Receptor Radionuclide Therapy Using Ga-68 Somatostatin Re...